-+ 0.00%
-+ 0.00%
-+ 0.00%

Ascendiant Capital Maintains Buy on Aemetis, Raises Price Target to $20

Benzinga·06/06/2025 10:42:19
Listen to the news
Ascendiant Capital analyst Edward Woo maintains Aemetis (NASDAQ:AMTX) with a Buy and raises the price target from $19 to $20.